| Journal of Enzyme Inhibition and Medicinal Chemistry | 卷:35 |
| Synthesis, in vitro inhibitory activity, kinetic study and molecular docking of novel N-alkyl–deoxynojirimycin derivatives as potential α-glucosidase inhibitors | |
| En Yuan1  Da-Yong Peng2  Xu-Liang Nie2  Jia-Cheng Zeng3  Ji-Guang Chen3  Zhong-Ping Yin3  Ping Lin3  Xiao-Qiang Wang4  | |
| [1] College of Pharmacy, Jiangxi University of Traditional Chinese Medicine; | |
| [2] College of Science, Jiangxi Agricultural University; | |
| [3] Jiangxi Key Laboratory of Natural Products and Functional Foods, Jiangxi Agricultural University; | |
| [4] State Key Laboratory of Medicinal Chemical Biology and College of Pharmacy, Nankai University; | |
| 关键词: 1-deoxynojirimycin derivatives; α-glucosidase; inhibitor; structure–activity relationship; docking study; | |
| DOI : 10.1080/14756366.2020.1826941 | |
| 来源: DOAJ | |
【 摘 要 】
A series of novel N-alkyl-1-deoxynojirimycin derivatives 25 ∼ 44 were synthesised and evaluated for their in vitro α-glucosidase inhibitory activity to develop α-glucosidase inhibitors with high activity. All twenty compounds exhibited α-glucosidase inhibitory activity with IC50 values ranging from 30.0 ± 0.6 µM to 2000 µM as compared to standard acarbose (IC50 = 822.0 ± 1.5 µM). The most active compound 43 was ∼27-fold more active than acarbose. Kinetic study revealed that compounds 43, 40, and 34 were all competitive inhibitors on α-glucosidase with Ki of 10 µM, 52 µM, and 150 µM, respectively. Molecular docking demonstrated that the high active inhibitors interacted with α-glucosidase by four types of interactions, including hydrogen bonds, π–π stacking interactions, hydrophobic interactions, and electrostatic interaction. Among all the interactions, the π–π stacking interaction and hydrogen bond played a significant role in a various range of activities of the compounds.
【 授权许可】
Unknown